Search results
Results from the WOW.Com Content Network
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...
The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. [2]
The Cincinnati Prehospital Stroke Scale (abbreviated CPSS) is a system used to diagnose a potential stroke in a prehospital setting. [1] It tests three signs for abnormal findings which may indicate that the patient is having a stroke.
For example, a person aged 60 (1 point) with normal blood pressure (0 point) and without diabetes (0 point) who experienced a TIA lasting 10 minutes (1 point) with a speech disturbance but no weakness on one side of the body (1 point) would score a total of 3 points.
The European Society of Cardiology (ESC), [25] and National Institute for Health and Care Excellence (NICE) [27] guidelines recommend that if the patient has a CHA 2 DS 2-VASc score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct oral anticoagulant ...
The Consensus Development Program is an initiative focused on gathering expert opinions to establish standards and guidelines in various fields, especially in health and medicine. Developed as a collaborative effort by organizations such as the NIH, the program assembles panels of specialists who assess available evidence on critical topics and ...
The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.
Current guidelines recommend antiplatelet therapy for patients with non-cardioembolic ischemic stroke. [ 8 ] [ 9 ] [ 10 ] However, it is widely believed that there is a substantial overlap between ESUS and cardioembolic stroke, clinical trials have assessed the benefit of anticoagulation versus antiplatelet agents for preventing recurrent stroke.